phosphatidylcholines has been researched along with 5-(n,n-hexamethylene)amiloride in 1 studies
| Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (5-(n,n-hexamethylene)amiloride) | Trials (5-(n,n-hexamethylene)amiloride) | Recent Studies (post-2010) (5-(n,n-hexamethylene)amiloride) |
|---|---|---|---|---|---|
| 32,204 | 443 | 5,593 | 145 | 0 | 34 |
| Protein | Taxonomy | phosphatidylcholines (IC50) | 5-(n,n-hexamethylene)amiloride (IC50) |
|---|---|---|---|
| Urokinase-type plasminogen activator | Homo sapiens (human) | 2.4 | |
| Adenosine receptor A2a | Homo sapiens (human) | 2.685 | |
| Adenosine receptor A2b | Homo sapiens (human) | 0.27 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 3.3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakajima, N; Nakaya, H; Tamagawa, M; Yamaguchi, S | 1 |
1 other study(ies) available for phosphatidylcholines and 5-(n,n-hexamethylene)amiloride
| Article | Year |
|---|---|
Selective impairment of HCO3(-)-dependent pHi regulation by lysophosphatidylcholine in guinea pig ventricular myocardium.
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Amiloride; Animals; Carrier Proteins; Guinea Pigs; Hydrogen-Ion Concentration; Intracellular Fluid; Lysophosphatidylcholines; Membrane Potentials; Myocardial Ischemia; Myocardium; Papillary Muscles; Phosphatidylcholines; Sodium-Bicarbonate Symporters; Sodium-Hydrogen Exchangers | 1998 |